Published Nov 9, 2015

SESSION EXPLORES OPPORTUNITIES AND CHALLENGES FOR MEDICAL DEVICES

Milan, Italy—November 9, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18^th Annual European Congress Issue Panel 2 explored the issue of, “Possible Increased Synergy Between Health Technology Assessment (HTA) and Regulatory Agencies: Opportunity or Challenge for Medical Devices?.” This issue panel was held this morning at the MiCo – Milano Congressi in Milan, Italy. The issue panel was moderated by Christopher Henshall, PhD, Associate Professor, Health Economics Research, Brunel University, London, UK and included panelists: - Pascale Brasseur, EconD, Chair, HTA Working Group, Eucomed, Brussels, Belgium - Les Levin, MA, MD, Founding Chief Scientific Officer, MaRS EXCITE, Toronto, ON, Canada - François Meyer, MD, Advisor to the President, International Affairs, French National Authority for Health (HAS), Paris, France Released presentations from the ISPOR 18^th Annual European Congress are available at http://www.ispor.org/Event/ReleasedPresentations/2015Milan. ISPOR’s 18^th Annual European Congress may be followed on social media using the hashtag #ISPORMilan. ISPOR’s Medical Devices and Diagnostics Special Interest Group is currently developing a report on the challenges and possible solutions for value assessment of medical devices through their Value Assessment of Medical Device Working Group.

###